Predictive potential of dynamic contrast-enhanced MRI and plasma-derived angiogenic factors for response to concurrent chemoradiotherapy in human papillomavirus-negative oropharyngeal cancer

1. Barsouk A, Aluru JS, Rawla P, Saginala K, Barsouk A. Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma. Med Sci 2023; 11: 42. doi: 10.3390/medsci11020042 BarsoukA AluruJS RawlaP SaginalaK BarsoukA Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma Med Sci 2023 11 42 10.3390/medsci11020042 Open DOISearch in Google Scholar

2. Shinomiya H, Nibu KI. Etiology, diagnosis, treatment, and prevention of human papilloma virus-associated oropharyngeal squamous cell carcinoma. Int J Clin Oncol 2023; 28: 975–81. doi: 10.1007/s10147-023-02336-8 ShinomiyaH NibuKI Etiology, diagnosis, treatment, and prevention of human papilloma virus-associated oropharyngeal squamous cell carcinoma Int J Clin Oncol 2023 28 975 81 10.1007/s10147-023-02336-8 Open DOISearch in Google Scholar

3. Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther 2023; 8: 70. doi: 10.1038/s41392-023-01332-8 ChenZ HanF DuY ShiH ZhouW Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions Signal Transduct Target Ther 2023 8 70 10.1038/s41392-023-01332-8 Open DOISearch in Google Scholar

4. Martens RM, Noij DP, Ali M, Koopman T, Marcus JT, Vergeer MR, et al. Functional imaging early during (chemo)radiotherapy for response prediction in head and neck squamous cell carcinoma; a systematic review. Oral Oncol 2019; 88: 75–83. doi: 10.1016/j.oraloncology.2018.11.005 MartensRM NoijDP AliM KoopmanT MarcusJT VergeerMR Functional imaging early during (chemo)radiotherapy for response prediction in head and neck squamous cell carcinoma; a systematic review Oral Oncol 2019 88 75 83 10.1016/j.oraloncology.2018.11.005 Open DOISearch in Google Scholar

5. Bos P, van der Hulst HJ, van den Brekel MWM, Schats W, Jasperse B, Beets-Tan RGH, et al. Prognostic functional MR imaging parameters in head and neck squamous cell carcinoma: a systematic review. Eur J Radiol 2021; 144: 109952. doi: 10.1016/j.ejrad.2021.109952 BosP van der HulstHJ van den BrekelMWM SchatsW JasperseB Beets-TanRGH Prognostic functional MR imaging parameters in head and neck squamous cell carcinoma: a systematic review Eur J Radiol 2021 144 109952 10.1016/j.ejrad.2021.109952 Open DOISearch in Google Scholar

6. Kikuchi R, Kikuchi Y, Tsuda H, Maekawa H, Kozaki K, Imoto I, et al. Expression and clinical significance of connective tissue growth factor in advanced head and neck squamous cell cancer. Hum Cell 2014; 27: 121–8. doi: 10.1007/s13577-014-0092-0 KikuchiR KikuchiY TsudaH MaekawaH KozakiK ImotoI Expression and clinical significance of connective tissue growth factor in advanced head and neck squamous cell cancer Hum Cell 2014 27 121 8 10.1007/s13577-014-0092-0 Open DOISearch in Google Scholar

7. Bran B, Bran G, Hörmann K, Riedel F. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated antiangiogenetic therapy in head and neck cancer. Int J Oncol 2009; 34: 255–61. doi: 10.3892/ijo_00000147 BranB BranG HörmannK RiedelF The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated antiangiogenetic therapy in head and neck cancer Int J Oncol 2009 34 255 61 10.3892/ijo_00000147 Open DOISearch in Google Scholar

8. Homer JJ, Greenman J, Stafford ND. Circulating angiogenic cytokines as tumour markers and prognostic factors in head and neck squamous cell carcinoma. Clin Otolaryngol Allied Sci 2002; 27: 32–7. doi: 10.1046/j.0307-7772.2001.00519.x HomerJJ GreenmanJ StaffordND Circulating angiogenic cytokines as tumour markers and prognostic factors in head and neck squamous cell carcinoma Clin Otolaryngol Allied Sci 2002 27 32 7 10.1046/j.0307-7772.2001.00519.x Open DOISearch in Google Scholar

9. Huang C, Zhou X, Li Z, Liu H, He Y, Ye G, et al. Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma. Mol Med Rep 2016; 14: 2489–96. doi: 10.3892/mmr.2016.5580 HuangC ZhouX LiZ LiuH HeY YeG Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma Mol Med Rep 2016 14 2489 96 10.3892/mmr.2016.5580 Open DOISearch in Google Scholar

10. Demšar J, Curk T, Erjavec A, Gorup Č, Hočevar T, Milutinovič M et al. Orange: Data Mining Toolbox in Python. J Mach Learn Res. 2013; 14: 2349–2353. DemšarJ CurkT ErjavecA GorupČ HočevarT MilutinovičM Orange: Data Mining Toolbox in Python J Mach Learn Res. 2013 14 2349 2353 Search in Google Scholar

11. McKinney W. Data structures for statistical computing in Python. Proceedings of the 9th Python in Science Conference, 2010; 51–56. McKinneyW Data structures for statistical computing in Python Proceedings of the 9th Python in Science Conference 2010 51 56 Search in Google Scholar

12. Hunter J D Matplotlib: A 2D Graphics Environment. Comput Sci Eng 2007; 9(3), 90–95. HunterJ D Matplotlib: A 2D Graphics Environment Comput Sci Eng 2007 9 3 90 95 Search in Google Scholar

13. Virtanen P, Gommers R, Oliphant T E, Haberland M, Reddy T, Cournapeau D, et. al. SciPy 1.0: Fundamental algorithms for scientific computing in Python. Nature Methods 2020; 17(3), 261–272. VirtanenP GommersR OliphantT E HaberlandM ReddyT CournapeauD SciPy 1.0: Fundamental algorithms for scientific computing in Python Nature Methods 2020 17 3 261 272 Search in Google Scholar

14. Bernstein JM, Homer JJ, West CM. Dynamic contrast-enhanced magnetic resonance imaging biomarkers in head and neck cancer: potential to guide treatment? A systematic review. Oral Oncol 2014; 50: 963–70. doi: 10.1016/j.oraloncology.2014.07.011 BernsteinJM HomerJJ WestCM Dynamic contrast-enhanced magnetic resonance imaging biomarkers in head and neck cancer: potential to guide treatment? A systematic review Oral Oncol 2014 50 963 70 10.1016/j.oraloncology.2014.07.011 Open DOISearch in Google Scholar

15. Dijkhoff RAP, Beets-Tan RGH, Lambregts DMJ, Beets GL, Maas M. Value of DCE-MRI for staging and response evaluation in rectal cancer: a systematic review. Eur J Radiol 2017; 95: 155–68. doi: 10.1016/j.ejrad.2017.08.009 DijkhoffRAP Beets-TanRGH LambregtsDMJ BeetsGL MaasM Value of DCE-MRI for staging and response evaluation in rectal cancer: a systematic review Eur J Radiol 2017 95 155 68 10.1016/j.ejrad.2017.08.009 Open DOISearch in Google Scholar

16. Ng SH, Liao CT, Lin CY, Chan SC, Lin YC, Yen TC, et al. Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation. Eur Radiol 2016; 26: 4162–72. doi: 10.1007/s00330-016-4276-8 NgSH LiaoCT LinCY ChanSC LinYC YenTC Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation Eur Radiol 2016 26 4162 72 10.1007/s00330-016-4276-8 Open DOISearch in Google Scholar

17. Chan SC, Cheng NM, Hsieh CH, Ng SH, Lin CY, Yen TC, et al. Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy. Oncotarget 2017; 8: 62606–21. doi: 10.18632/onco-target.15904 ChanSC ChengNM HsiehCH NgSH LinCY YenTC Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy Oncotarget 2017 8 62606 21 10.18632/onco-target.15904 Open DOISearch in Google Scholar

18. Ng SH, Lin CY, Chan SC, Yen TC, Liao CT, Chang JT, et al. Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy. PLoS One 2013; 8: e72230. doi: 10.1371/journal.pone.0072230 NgSH LinCY ChanSC YenTC LiaoCT ChangJT Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy PLoS One 2013 8 e72230 10.1371/journal.pone.0072230 Open DOISearch in Google Scholar

19. Baer AH, Hoff BA, Srinivasan A, Galbán CJ, Mukherji SK. Feasibility analysis of the parametric response map as an early predictor of treatment efficacy in head and neck cancer. Am J Neuroradiol 2015; 36: 757–62. doi: 10.3174/ajnr.A4296 BaerAH HoffBA SrinivasanA GalbánCJ MukherjiSK Feasibility analysis of the parametric response map as an early predictor of treatment efficacy in head and neck cancer Am J Neuroradiol 2015 36 757 62 10.3174/ajnr.A4296 Open DOISearch in Google Scholar

20. Wong KH, Panek R, Dunlop A, Mcquaid D, Riddell A, Welsh LC, et al. Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer. Eur J Nucl Med Mol Imaging 2018; 45: 759–67. doi: 10.1007/s00259-017-3890-2 WongKH PanekR DunlopA McquaidD RiddellA WelshLC Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer Eur J Nucl Med Mol Imaging 2018 45 759 67 10.1007/s00259-017-3890-2 Open DOISearch in Google Scholar

21. Yamazaki T, Young KH. Effects of radiation on tumor vasculature. Mol Carcinog 2022; 61: 165–72. doi: 10.1002/mc.23360 YamazakiT YoungKH Effects of radiation on tumor vasculature Mol Carcinog 2022 61 165 72 10.1002/mc.23360 Open DOISearch in Google Scholar

22. Bisdas S, Seitz O, Middendorp M, Chambron-Pinho N, Bisdas T, Vogl TJ, et al. An exploratory pilot study into the association between microcirculatory parameters derived by MRI-based pharmacokinetic analysis and glucose utilization estimated by PET-CT imaging in head and neck cancer. Eur Radiol 2010; 20: 2358–66. doi: 10.1007/s00330-010-1803-x BisdasS SeitzO MiddendorpM Chambron-PinhoN BisdasT VoglTJ An exploratory pilot study into the association between microcirculatory parameters derived by MRI-based pharmacokinetic analysis and glucose utilization estimated by PET-CT imaging in head and neck cancer Eur Radiol 2010 20 2358 66 10.1007/s00330-010-1803-x Open DOISearch in Google Scholar

23. Galbraith SM. MR in oncology drug development. NMR Biomed 2006; 19: 681–9. doi: 10.1002/nbm.1093 GalbraithSM MR in oncology drug development NMR Biomed 2006 19 681 9 10.1002/nbm.1093 Open DOISearch in Google Scholar

24. Lowry M, Zelhof B, Liney GP, Gibbs P, Pickles MD, Turnbull LW. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue. Invest Radiol 2009; 44: 577–84. doi: 10.1097/RLI.0b013e3181b4c1fe LowryM ZelhofB LineyGP GibbsP PicklesMD TurnbullLW Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue Invest Radiol 2009 44 577 84 10.1097/RLI.0b013e3181b4c1fe Open DOISearch in Google Scholar

25. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646–74. doi: 10.1016/j.cell.2011.02.013 HanahanD WeinbergRA Hallmarks of cancer: the next generation Cell 2011 144 646 74 10.1016/j.cell.2011.02.013 Open DOISearch in Google Scholar

26. Kut C, Mac Gabhann F, Popel AS. Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer. Br J Cancer 2007; 97: 978–85. doi: 10.1038/sj.bjc.6603923 KutC Mac GabhannF PopelAS Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer Br J Cancer 2007 97 978 85 10.1038/sj.bjc.6603923 Open DOISearch in Google Scholar

27. Macedo F, Ladeira K, Longatto-Filho A, Martins SF. Gastric cancer and angiogenesis: is VEGF a useful biomarker to assess progression and remission? J Gastric Cancer 2017; 17: 1–10. doi: 10.5230/jgc.2017.17.e1 MacedoF LadeiraK Longatto-FilhoA MartinsSF Gastric cancer and angiogenesis: is VEGF a useful biomarker to assess progression and remission? J Gastric Cancer 2017 17 1 10 10.5230/jgc.2017.17.e1 Open DOISearch in Google Scholar

28. Liu B, Gao H, Zhou F, Zhao W, Yang Y. Dynamic contrast-enhanced magnetic resonance imaging in cervical cancer: correlation between quantitative parameters and molecular markers hypoxia-inducible factors-1-alpha, vascular endothelial growth factor, and Ki-67. Clin Radiol 2024; 79: e826–e33. doi: 10.1016/J.CRAD.2024.01.039 LiuB GaoH ZhouF ZhaoW YangY Dynamic contrast-enhanced magnetic resonance imaging in cervical cancer: correlation between quantitative parameters and molecular markers hypoxia-inducible factors-1-alpha, vascular endothelial growth factor, and Ki-67 Clin Radiol 2024 79 e826 e33 10.1016/J.CRAD.2024.01.039 Open DOISearch in Google Scholar

29. Di N, Cheng W, Jiang X, Liu X, Zhou J, Xie Q, et al. Can dynamic contrast-enhanced MRI evaluate VEGF expression in brain glioma? An MRI-guided stereotactic biopsy study. J Neuroradiol 2019; 46: 186–92. doi: 10.1016/j.neurad.2018.04.008 DiN ChengW JiangX LiuX ZhouJ XieQ Can dynamic contrast-enhanced MRI evaluate VEGF expression in brain glioma? An MRI-guided stereotactic biopsy study J Neuroradiol 2019 46 186 92 10.1016/j.neurad.2018.04.008 Open DOISearch in Google Scholar

30. Lindgren A, Anttila M, Arponen O, Rautiainen S, Könönen M, Vanninen R, et al. Prognostic value of preoperative dynamic contra st-enhanced magnetic resonance imaging in epithelial ovarian cancer. Eur J Radiol 2019; 115: 66–73. doi: 10.1016/j.ejrad.2019.03.023 LindgrenA AnttilaM ArponenO RautiainenS KönönenM VanninenR Prognostic value of preoperative dynamic contra st-enhanced magnetic resonance imaging in epithelial ovarian cancer Eur J Radiol 2019 115 66 73 10.1016/j.ejrad.2019.03.023 Open DOISearch in Google Scholar

31. Keil VC, Pintea B, Gielen GH, Hittatiya K, Datsi A, Simon M, et al. Meningioma assessment: kinetic parameters in dynamic contrast-enhanced MRI appear independent from microvascular anatomy and VEGF expression. J Neuroradiol 2018; 45: 242–8. doi: 10.1016/j.neurad.2018.01.050 KeilVC PinteaB GielenGH HittatiyaK DatsiA SimonM Meningioma assessment: kinetic parameters in dynamic contrast-enhanced MRI appear independent from microvascular anatomy and VEGF expression J Neuroradiol 2018 45 242 8 10.1016/j.neurad.2018.01.050 Open DOISearch in Google Scholar

32. Kulapaditharom B, Boonkitticharoen V, Sritara C. Plasma vascular endothelial growth factor dysregulation in defining aggressiveness of head and neck squamous cell carcinoma. J Oncol 2012; 2012: 687934. doi: 10.1155/2012/687934 KulapaditharomB BoonkitticharoenV SritaraC Plasma vascular endothelial growth factor dysregulation in defining aggressiveness of head and neck squamous cell carcinoma J Oncol 2012 2012 687934 10.1155/2012/687934 Open DOISearch in Google Scholar

33. Siemert J, Wald T, Kolb M, Pettinella I, Böhm U, Pirlich M, et al. Pretherapeutic VEGF level in plasma is a prognostic bio-marker in head and neck squamous cell carcinoma (HNSCC). Cancers 2021; 13: 3781. doi: 10.3390/cancers13153781 SiemertJ WaldT KolbM PettinellaI BöhmU PirlichM Pretherapeutic VEGF level in plasma is a prognostic bio-marker in head and neck squamous cell carcinoma (HNSCC) Cancers 2021 13 3781 10.3390/cancers13153781 Open DOISearch in Google Scholar

34. Dumitru CS, Raica M. Vascular endothelial growth factor family and head and neck squamous cell carcinoma. Anticancer Res 2023; 43: 4315–26. doi: 10.21873/anticanres.16626 DumitruCS RaicaM Vascular endothelial growth factor family and head and neck squamous cell carcinoma Anticancer Res 2023 43 4315 26 10.21873/anticanres.16626 Open DOISearch in Google Scholar

35. Laschke MW, Elitzsch A, Vollmar B, Vajkoczy P, Menger MD. Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions. Hum Reprod 2006; 21: 262–8. doi: 10.1093/humrep/dei308 LaschkeMW ElitzschA VollmarB VajkoczyP MengerMD Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions Hum Reprod 2006 21 262 8 10.1093/humrep/dei308 Open DOISearch in Google Scholar